Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Takahiro Beppu
Trough Level of Infliximab Is Useful for Assessing Mucosal Healing in Crohn's Disease: A Prospective Cohort Study
Intestinal Research
Gastroenterology
Related publications
Higher Infliximab Trough Levels Are Associated With Perianal Fistula Healing in Patients With Crohn's Disease
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Early Vedolizumab Trough Levels Predict Mucosal Healing in Inflammatory Bowel Disease: A Multicentre Prospective Observational Study
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Editorial: Infliximab Trough Cut-Off for Perianal Crohn's Disease - Another Piece of the Therapeutic Drug Monitoring-Guided Infliximab Dosing Puzzle
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
New England Journal of Medicine
Medicine
Efficacy of Infliximab Biosimilars in Patients With Crohn's Disease
The Lancet
Medicine
PWE-248 Docosahexanoeic Acid in the Aetiology of Crohn's Disease—data From a European Prospective Cohort Study (EPIC)
Gut
Gastroenterology
Löfgren Syndrome Developing During Infliximab Therapy for Crohn's Disease: A Case Report
Canadian Journal of General Internal Medicine
Löfgren Syndrome Developing During Infliximab Therapy for Crohn's Disease: A Case Report
Canadian Journal of General Internal Medicine
Infliximab Treatment Time and the Mucosal Healing Effect in Pediatric Patients With Severe Crohn’s Disease – Own Experience
Przeglad Gastroenterologiczny
Gastroenterology